technetium tc 99m hydroxymethylene diphosphonate has been researched along with Jaw Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arce, K; Assael, LA; Markiewicz, MR; Weissman, JL | 1 |
| Arias, JA; Cuadrado, ML; Olmos, A; Pardo, C; Ruibal, A | 1 |
1 review(s) available for technetium tc 99m hydroxymethylene diphosphonate and Jaw Diseases
| Article | Year |
|---|---|
Imaging findings in bisphosphonate-related osteonecrosis of jaws.
Topics: Bone Density Conservation Agents; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Magnetic Resonance Imaging; Osteonecrosis; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2009 |
1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Jaw Diseases
| Article | Year |
|---|---|
Dental diseases and radionuclide imaging of the jaws.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Jaw; Jaw Diseases; Male; Medical History Taking; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tooth Diseases | 2004 |